Valid Ghana · FDA Ghana

ACNERON CREAM (Each 30gm tube contains Clobetasol Propionate 0.05%w/w)

CLOBESTASOL PROPIONATE

FDA/SD.245-071144 CREAM 0.05%w/w

What it does

Clobetasol is a strong topical steroid used to reduce inflammation and treat skin conditions.

Commonly used for: eczema, psoriasis, dermatitis, inflammatory skin disorders

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.245-071144
Registration date
2024-07-16
Expiry date
2029-04-01
Status
Valid
Active ingredient
CLOBESTASOL PROPIONATE
Dosage form
CREAM
Strength
0.05%w/w
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Roxin Ghana
Country of origin
-
Manufacturer location
HRC6+WGH, Osu Ave Extension, Accra, Ghana

Source: Food and Drugs Authority · fetched 2026-04-18 08:32:59 · updated 2026-10-30 04:00:06

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Clobetasol is a strong topical steroid used to reduce inflammation and treat skin conditions.

What it treats

  • eczema
  • psoriasis
  • dermatitis
  • inflammatory skin disorders

How it works

Clobetasol works by reducing swelling, redness, and itching in the affected skin areas.

Who it's for

This medication is for adults and children with certain skin conditions that need strong treatment.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: clobestasol

Clobetasol is a highly potent topical corticosteroid used for its anti-inflammatory and immunosuppressive properties. It is primarily indicated for the treatment of various inflammatory skin disorders, including psoriasis and eczema. Due to its potency, clobetasol is typically reserved for short-term use in severe conditions or for localized inflammatory lesions when less potent agents are ineffective.

Indications

  • Psoriasis
  • Eczema
  • Contact dermatitis
  • Seborrheic dermatitis
  • Lichen planus
  • Nummular dermatitis

Dosage

Children: For children, the use of clobetasol should be guided by a healthcare professional, with consideration for the child's age, weight, and specific skin condition. Refer to the BNF for Children for detailed dosing recommendations.

Adults: For adults, clobetasol is typically applied to the affected area once or twice daily, depending on the specific formulation and severity of the condition. It is important to follow specific guidance from a healthcare professional.

Mechanism of action

Clobetasol exerts its effects by binding to the glucocorticoid receptor, leading to the regulation of gene expression. This results in the inhibition of pro-inflammatory cytokines and chemokines, suppression of inflammatory cell infiltration, and reduction of immune responses. The drug also stabilizes lysosomal membranes, preventing the release of enzymes that can cause tissue damage.

Pharmacodynamics

Clobetasol has a high affinity for the glucocorticoid receptor, making it one of the most potent corticosteroids available. Its anti-inflammatory effects help decrease redness, swelling, and itching associated with dermatologic conditions. The drug's potency allows for effective treatment of severe skin conditions with minimal doses, reducing the risk of systemic absorption and side effects.

Pharmacokinetics

Clobetasol is well-absorbed through the skin, with systemic absorption depending on the vehicle used and the condition of the skin. Once absorbed, it is metabolized mainly in the liver, and its metabolites are excreted in urine. The half-life of clobetasol is variable, but it is typically eliminated quickly from the body due to its extensive first-pass metabolism.

Contra-indications

  • Hypersensitivity to clobetasol or any of its excipients
  • Untreated bacterial, viral, or fungal infections
  • Rosacea
  • Acne vulgaris
  • Perioral dermatitis

Adverse effects

  • Skin atrophy
  • Striae
  • Telangiectasia
  • Systemic absorption leading to adrenal suppression
  • Hypopigmentation
  • Allergic contact dermatitis
  • Burning, itching, or irritation at the application site

Interactions

  • Concurrent use with other topical corticosteroids may enhance effects and increase risk of systemic effects
  • Potential interactions with drugs that affect the metabolism of corticosteroids

Precautions

  • Use with caution in patients with a history of adrenal insufficiency
  • Avoid prolonged use especially in children and on large surface areas
  • Monitor for signs of systemic absorption, especially in high-potency formulations
  • Avoid contact with eyes and mucous membranes

Pregnancy

Clobetasol should be used in pregnancy only if the benefits outweigh the risks. Long-term use or application over large areas should be avoided.

Breast-feeding

Clobetasol can be used while breastfeeding, but caution should be exercised. The smallest effective dose should be used for the shortest duration necessary.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

  • Topical cream
  • Topical ointment
  • Topical lotion
  • Topical gel

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.